Author:
Bisson Eva,Piton Louis,Durand Bénédicte,Sarrade Thomas,Huguet Florence
Reference30 articles.
1. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial;Conroy;Lancet Oncol,2021
2. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial;Bahadoer;Lancet Oncol,2021
3. Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older;Margalit;Int J Radiat Oncol Biol Phys,2011
4. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial;Erlandsson;Lancet Oncol. mars,2017
5. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer;Pettersson;Br J Surg. avr,2010